SG-INSIGHT study will extend whole- genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore’s healthcare system
SINGAPORE –
Media OutReach Newswire – 3 November 2026 – Illumina, Inc.